Are you Dr. Marzan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Ms# 60
Los Angeles, CA 90027Phone+1 323-361-2119Fax+1 323-361-1130
Summary
- Dr. Katherine Marzan, MD is a pediatric rheumatologist in Los Angeles, California. She is currently licensed to practice medicine in California, Nevada, and Louisiana. She is affiliated with Children's Hospital Los Angeles, Torrance Memorial Medical Center, and Long Beach Medical Center.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Rheumatology, 1993 - 1996
- Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1990 - 1993
- University of the Philippines College of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 2002 - 2026
- NV State Medical License 2010 - 2025
- PA State Medical License 1992 - 2004
- LA State Medical License 1996 - 2003
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 39 citationsLong-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trialSeza Ozen, Eldad Ben-Cherit, Ivan Foeldvari, Gil Amarilyo, Huri Ozdogan
Annals of the Rheumatic Diseases. 2020-06-22 - 21 citationsTapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study.Pierre Quartier, Ekaterina Alexeeva, Tamás Constantin, Vyacheslav Chasnyk, Nico M Wulffraat
Arthritis & Rheumatology. 2021-02-01 - 20 citationsEfficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treat...Hermine I. Brunner, Pierre Quartier, Ekaterina Alexeeva, Tamás Constantin, Isabelle Koné-Paut
Arthritis & Rheumatology. 2020-12-01
Professional Memberships
- Fellow